Eczema Cream Recall Due to Contamination Risk for El Paso Residents

Want the full story?
Read the complete article at KTSM
AI Summary
A recall has been issued for the MG217 Multi-symptom Treatment Cream & Skin Protectant Eczema Cream, produced by Pharmacal, after it was discovered to be contaminated with Staphylococcus aureus, a bacteria that can cause severe infections. The FDA announced the recall on Tuesday, highlighting the potential risk of life-threatening staph infections associated with the use of this product. Consumers in El Paso who have purchased this cream should check their medicine cabinets and discontinue use immediately. The recall underscores the importance of monitoring health products for safety concerns.
Key Details: • Check for MG217 Multi-symptom Treatment Cream in your home. • Discontinue use if you have this product. • Stay informed about further updates from the FDA regarding this recall.